Skip to main content
. 2021 May 5;7:48. doi: 10.1038/s41523-021-00256-2

Fig. 2. Disease-free survival in Luminal B early breast cancer patients according to CINSARC signature.

Fig. 2

a Kaplan–Meier disease-free survival (DFS) in Luminal B breast cancer patients according to the two CINSARC classes (high-risk versus low-risk) in the overall population. b Similar to a, but only in patients receiving adjuvant endocrine therapy but no adjuvant chemotherapy.